
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The binge eating disorder market was valued at USD 0.81 Billion in 2024 driven by increasing awareness, advancements in treatment options, and the rising prevalence of the disorder across the 8 major markets. It is expected to grow at a CAGR of 6.00% during the forecast period 2025-2034 and attain a market value of USD 1.45 Billion by 2034.
Base Year
Historical Period
Forecast Period
The rising prevalence of eating disorders is a primary driver of the market. As per the Eating Recovery Center’s Eating Disorder Statistics 2024, 28.8 million Americans, or 9% of the United States population will experience an eating disorder at some point in their lives.
Providing adequate education about the condition and its treatment is amongst the major market trends. For instance, Monte Nido & Affiliates, a leading eating disorder treatment provider in the United States educated on binge eating disorder during National Eating Disorders Awareness Week in February 2024.
The robust regulatory support from health authorities like the FDA and ongoing research and development efforts to improve therapeutic options for binge eating disorders are likely to elevate the market value in the forecast period.
Compound Annual Growth Rate
6%
Value in USD Billion
2025-2034
Binge Eating Disorder Market Outlook
*this image is indicative*
Binge eating disorder (BED) is characterized by excessive eating within a short period, without engaging in purging behaviors such as vomiting. It can result in obesity, heart disease, and emotional problems. BED is the result of a combination of genetic, psychological, and environmental factors such as genetics, lack of self-confidence, and societal influences. Binge episodes can be exacerbated by stress and negative emotions.
Genetic factors, hormonal imbalances, and dopamine are all factors that influence the development and severity of the disorder. Mental health problems such as depression, anxiety, and previous trauma can lead to episodes of binge eating, along with emotional stressors. Societal expectations, limited eating habits, and genetic predisposition for eating disorders may elevate the chances of developing one.
Binge eating disorder treatment typically includes a mix of counseling, drugs, and adjustments in lifestyle. Cognitive behavioral therapy (CBT) is successful in handling triggers, while drugs such as lisdexamfetamine and antidepressants aid in diminishing cravings and balancing mood.
Increasing Prevalence of Binge Eating Disorder Spurs Market Growth
The rising occurrence of binge eating disorder is driving the growth of the market as awareness of mental health increases. As per the Eating Recovery Center’s eating disorder statistics for 2024, 28.8 million Americans, or 9% of the U.S. population, will experience an eating disorder at some point in their lives. Each year, 10,200 deaths occur due to eating disorders, resulting in one death every 52 minutes. Urbanization, inactive lifestyles, and high-stress levels lead to a rise in BED cases, particularly in developed areas.
Growing Awareness and Diagnosis to Meet Rising Binge Eating Disorder Market Demand
Efforts in public health campaigns and education have contributed to raising awareness of BED as a significant mental health condition. During the National Eating Disorders Awareness Week in February 2024, Monte Nido & Affiliates conducted an educative session on binge eating disorder. As a leading eating disorder treatment provider in the United States, they offer vital resources and expanded virtual treatment programs in 28 states. Their specialty program addresses core features of shame, guilt, and self-blame associated with binge eating disorder, encouraging individuals to seek help for mental health issues without fear of judgment has led to an increase in early diagnoses. Healthcare providers have improved their skills in recognizing BED, resulting in an increased need for treatment choices.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The EMR’s report titled “Binge Eating Disorder Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Drug Class
Market Breakup by Route of Administration
Market Breakup by Distribution Channel
Market Breakup by Region
Market Share Based on Route of Administration to Witness Substantial Growth
Based on the route of administration, the market is divided into oral, parenteral, and others. The most frequent administration is through oral administration, where drugs such as lisdexamfetamine and antidepressants can be easily included in daily schedules. Oral medications allow for flexibility in dosage and self-administration, increasing accessibility and affordability for long-term treatment.
Based on region, the market report covers the United States, EU-4 (Germany, France, Italy, Spain), United Kingdom, Japan, and India.
The United States is expected to dominate the market because of the high prevalence of the disorder and the availability of advanced treatment options, along with extensive awareness initiatives and strong healthcare facilities encouraging treatment acceptance. Drugs such as lisdexamfetamine and treatments like CBT are frequently utilized, supported by insurance and government efforts.
There has been a significant increase in market growth in the EU-4 countries and the United Kingdom due to the rising awareness of eating disorders as serious health issues, leading to more investment in mental health services and a higher demand for treatments. The market in Japan and India is rapidly expanding driven by greater awareness, diagnosis rates,h ealthcare infrastructure enhancements, lifestyle modifications, urbanization, and stress.
The key features of the market report include patent analysis, grant analysis, funding, and investment analysis, clinical trials analysis as well as strategic initiatives by the leading players. The major companies in the market are as follows:
Tonix Pharmaceuticals is a biopharmaceutical company dedicated to creating new treatments for central nervous system disorders, immunology conditions, infectious diseases, and rare diseases. In July 2023, they started enrolling participants in the MGH Phase 2 'STROBE' Study of TNX-1900 (Intranasal Potentiated Oxytocin) for the treatment of binge-eating disorder in July 2023.
Chronos Therapeutics Ltd is a UK-based pharmaceutical company focused on developing drugs for neurodegenerative diseases. They are a major player in the binge eating disorder market, utilizing Orexin -1 Antagonist research for effective treatment with minimal side effects.
Pyramid Healthcare offers a range of healthcare services in the United States, including residential and outpatient treatment, dual diagnosis, mental health, transitional housing, and specialty programs for substance abuse, mental health, autism, and eating disorders.
Eli Lilly and Company in Indianapolis, Indiana is a healthcare company developing medications for various health conditions. The FDA approved Lilly's Zepbound (tirzepatide) in November 2023 for chronic weight management, providing a new treatment option for those struggling with obesity or being overweight with weight-related medical issues.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other players in the market are Takeda Pharmaceutical Company Limited, VIVUS LLC, Sunovion Pharmaceuticals Inc., H. Lundbeck A/S, Orexigen Therapeutics Inc., Jazz Pharmaceuticals Inc., and Novo Nordisk A/S.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
REPORT FEATURES | DETAILS |
Base Year | 2024 |
Historical Period | 2018-2024 |
Forecast Period | 2025-2034 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Drug Class |
|
Breakup by Route of Administration |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.